| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.004 |